Literature DB >> 32571974

Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic.

Kevin J Monahan1,2, Anne Lincoln3, James E East4, Sally Benton5, John Burn6, Bianca DeSouza7, Helen Hanson8, Fiona Lalloo9, Terri McVeigh10, Matthew D Rutter11,12, Katie Snape8, Huw J W Thomas13,2, Peter Sasieni3.   

Abstract

Entities:  

Keywords:  cancer syndromes; colonoscopy; colorectal cancer; inherited cancers; surveillance

Year:  2020        PMID： 32571974     DOI： 10.1136/gutjnl-2020-321993

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  5 in total

1.  Diagnosis and management of Lynch syndrome.

Authors:  Penelope Edwards; Kevin J Monahan
Journal:  Frontline Gastroenterol       Date:  2022-06-02

2.  Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.

Authors:  Patrick R Benusiglio; Clément Korenbaum; Roseline Vibert; Joël Ezenfis; Sophie Geoffron; Charlotte Paul; Sandrine Richard; Veronique Byrde; Manon Lejeune; Erell Guillerm; Noemie Basset; Jean-Pierre Lotz; Nathalie Chabbert-Buffet; Joseph Gligorov; Florence Coulet
Journal:  Eur J Med Genet       Date:  2020-11-10       Impact factor: 2.708

Review 3.  Colorectal Cancer Screening and Surveillance for Non-Hereditary High-Risk Groups-Is It Time for a Re-Think?

Authors:  James S Hampton; Linda Sharp; Dawn Craig; Colin J Rees
Journal:  Curr Treat Options Gastroenterol       Date:  2021-01-05

Review 4.  Insight into prognostics, diagnostics, and management strategies for SARS CoV-2.

Authors:  Umay Amara; Sidra Rashid; Khalid Mahmood; Mian Hasnain Nawaz; Akhtar Hayat; Maria Hassan
Journal:  RSC Adv       Date:  2022-03-11       Impact factor: 3.361

Review 5.  The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients.

Authors:  María José Domper-Arnal; Gonzalo Hijos-Mallada; Ángel Lanas
Journal:  Therap Adv Gastroenterol       Date:  2022-08-22       Impact factor: 4.802
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.